Previously, in the context of LC, an association of mutations in the EGFR/KRAS genes and an increased expression of VEGFA/VEGFR2 in tumor tissue was demonstrated [25]. The gene discussed is VEGFA; the disease is laryngotracheoesophageal cleft.